glp 1 receptor agonists canada GLP-1 Access in Canada: Options, Costs & Clinical Considerations – PlexusDx View of Current Utilization Patterns
Description
[DOI] [PubMed] [Google Scholar] 294.Edfalk S., Steneberg P., Edlund H
There was no significant disparity in adverse reactions among the different preparations of GLP-1RA, among which the most common were gastrointestinal reactions, which mainly manifested as nausea, vomiting, and diarrhea
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin versus glimepiride in type 2 diabetes (CAROLINA)
Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS
